Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;14(11):e70166.
doi: 10.1002/brb3.70166.

Resting-State Electroencephalogram Complexity Is Associated With Oral Ketamine Treatment Response: A Bayesian Analysis of Lempel-Ziv Complexity and Multiscale Entropy

Affiliations

Resting-State Electroencephalogram Complexity Is Associated With Oral Ketamine Treatment Response: A Bayesian Analysis of Lempel-Ziv Complexity and Multiscale Entropy

Jules S Mitchell et al. Brain Behav. 2024 Nov.

Abstract

Introduction: Subanesthetic doses of ketamine are a promising novel treatment for suicidality; however, the evidence for predictive biomarkers is sparse. Recently, measures of complexity, including Lempel-Ziv complexity (LZC) and multiscale entropy (MSE), have been implicated in ketamine's therapeutic action. We evaluated electroencephalogram (EEG)-derived LZC and MSE differences between responders and nonresponders to oral ketamine treatment.

Methods: A total of 31 participants received six single, weekly (titrated) doses of oral racemic ketamine (0.5-3 mg/kg) and underwent EEG scans at baseline (Week 0), post-treatment (Week 6), and follow-up (Week 10). Resting-state (eyes closed and open) recordings were processed in EEGLAB, and complexity metrics were extracted using the Neurokit2 package. Participants were designated responders or nonresponders by clinical response (Beck Suicide Scale [BSS] score reduction of ≥ 50% from baseline to the respective timepoint or score ≤ 6) and then compared in terms of complexity across resting-state conditions and time.

Results: Employing a Bayesian mixed effects model, we found strong evidence that LZC was higher in the eyes-open compared to eyes-closed condition, as were MSE scales 1-3. At a global level, responders displayed elevated eyes-open baseline complexity compared to nonresponders, with these values decreasing from baseline to post-treatment (Week 6) in responders only. Exploratory analyses revealed that the elevated baseline eyes-open LZC in responders was spatially localized to the left frontal lobe (F1, AF3, FC1, and F3).

Conclusion: EEG-complexity metrics may be sensitive biomarkers for evaluating and predicting oral ketamine treatment response, with the left prefrontal cortex bein a possible treatment response region.

Keywords: complexity; electroencephalogram; ketamine; suicidality.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Estimated marginal means for multiscale entropy showing condition‐by‐scale interaction across timepoint and response status. Bars represent 95% highest posterior density. BAS, baseline; EC, eyes closed; EO, eyes open; FUP, follow‐up; NR, nonresponder; POST, posttreatment; RESP, responder.
FIGURE 2
FIGURE 2
Estimated marginal means for multiscale entropy showing response‐by‐scale interaction across timepoint and condition. Bars represent 95% highest posterior density. BAS, baseline; EC, eyes closed; EO, eyes open; FUP, follow‐up; NR, nonresponder; POST, posttreatment; RESP, responder.
FIGURE 3
FIGURE 3
Estimated marginal means for Lempel–Ziv complexity demonstrating condition‐by‐timepoint interaction across response status. Bars represent 95% highest posterior densities. BAS, baseline; EC, eyes closed; EO, eyes open; FUP, follow‐up; NR, nonresponder; POST, posttreatment; RESP, responder.
FIGURE 4
FIGURE 4
Estimated marginal means for Lempel–Ziv complexity showing timepoint‐by‐condition‐by‐response status interaction. Bars represent 95% highest posterior densities. BAS, baseline; EC, eyes closed; EO, eyes open; FUP, follow‐up; NR, nonresponder; POST, posttreatment; RESP, responder.
FIGURE 5
FIGURE 5
Topographical plot of by‐channel eyes‐open Lempel–Ziv complexity values at baseline for (A) responders, (B) nonresponders, and (C) the evidence (Bayes factors) for a difference between the groups.
FIGURE 6
FIGURE 6
Estimated marginal means for Lempel–Ziv complexity at channels Fp1, AF3, FC1, and F3, showing timepoint‐by‐condition‐response status interaction. Bars represent 95% highest posterior density. AF3, anterior‐frontal 3; BAS, baseline; EC, eyes closed; EO, eyes open; F3, frontal 3; FC1, fronto‐central 1; Fp1, frontal pole 1; FUP, follow‐up; NR, nonresponder; POST, posttreatment; RESP, responder.

References

    1. Abdallah, C. G. , Sanacora G., Duman R. S., and Krystal J. H.. 2018. “The Neurobiology of Depression, Ketamine and Rapid‐Acting Antidepressants: Is It Glutamate Inhibition or Activation?” Pharmacology & Therapeutics 190: 148–158. 10.1016/j.pharmthera.2018.05.010. - DOI - PMC - PubMed
    1. Abdallah, C. G. , De Feyter H. M., Averill L. A., et al. 2018. “The Effects of Ketamine on Prefrontal Glutamate Neurotransmission in Healthy and Depressed Subjects.” Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 43, no. 10: 2154–2160. 10.1038/s41386-018-0136-3. - DOI - PMC - PubMed
    1. Ali, F. , Gerhard D. M., Sweasy K., et al. 2020. “Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines.” Nature Communications 11: 72. 10.1038/s41467-019-13809-8. - DOI - PMC - PubMed
    1. Anijärv, T. E. , Can A. T., Gallay C. C., et al. 2023. “Spectral Changes of EEG Following a 6‐Week Low‐Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality.” International Journal of Neuropsychopharmacology 26: 259–267. 10.1093/ijnp/pyad006. - DOI - PMC - PubMed
    1. Arns, M. , Bruder G., Hegerl U., et al. 2016. “EEG Alpha Asymmetry as a Gender‐Specific Predictor of Outcome to Acute Treatment With Different Antidepressant Medications in the Randomized iSPOT‐D Study.” Clinical Neurophysiology 127: 509–519. 10.1016/j.clinph.2015.05.032. - DOI - PubMed

Grants and funding

LinkOut - more resources